| Year |
Citation |
Score |
| 2024 |
Evans TG, Castellino F, Kowalik Dobczyk M, Tucker G, Walley AM, Van Leuven K, Klein J, Rutkowski K, Ellis C, Eagling-Vose E, Treanor J, van Baalen C, Filkov E, Laurent C, Thacker J, et al. Assessment of CD8 T-cell mediated immunity in an influenza A(H3N2) human challenge model in Belgium: a single centre, randomised, double-blind phase 2 study. The Lancet. Microbe. PMID 38729196 DOI: 10.1016/S2666-5247(24)00024-7 |
0.319 |
|
| 2023 |
Dayan GH, Rouphael N, Walsh SR, Chen A, Grunenberg N, Allen M, Antony J, Bhate AS, Beresnev T, Bonaparte MI, Celle M, Ceregido MA, Corey L, Fu B, Grillet MH, ... ... Treanor J, et al. Efficacy of a monovalent (D614) SARS-CoV-2 recombinant protein vaccine with AS03 adjuvant in adults: a phase 3, multi-country study. Eclinicalmedicine. 64: 102168. PMID 37936652 DOI: 10.1016/j.eclinm.2023.102168 |
0.324 |
|
| 2022 |
Dayan GH, Rouphael N, Walsh SR, Chen A, Grunenberg N, Allen M, Antony J, Asante KP, Bhate AS, Beresnev T, Bonaparte MI, Angeles Ceregido M, Dobrianskyi D, Fu B, Grillet MH, ... ... Treanor J, et al. Efficacy of a bivalent (D614 + B.1.351) SARS-CoV-2 Protein Vaccine. Medrxiv : the Preprint Server For Health Sciences. PMID 36523415 DOI: 10.1101/2022.12.05.22282933 |
0.312 |
|
| 2021 |
Wang J, Li D, Perry S, Hilchey SP, Wiltse A, Treanor JJ, Sangster MY, Zand MS. Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains. Mbio. e0044921. PMID 34225490 DOI: 10.1128/mBio.00449-21 |
0.3 |
|
| 2021 |
Oshansky CM, King J, Lu D, Zhou J, Pavetto C, Horwith G, Biscardi K, Nguyen B, Treanor JJ, Chen LM, Jepson B, Bright RA, Johnson RA, Cioce V, et al. Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults. Npj Vaccines. 6: 41. PMID 33741987 DOI: 10.1038/s41541-021-00287-7 |
0.358 |
|
| 2020 |
Richards KA, Moritzky S, Shannon I, Fitzgerald T, Yang H, Branche A, Topham DJ, Treanor JJ, Nayak J, Sant AJ. Recombinant HA-based vaccine outperforms split and subunit vaccines in elicitation of influenza-specific CD4 T cells and CD4 T cell-dependent antibody responses in humans. Npj Vaccines. 5: 77. PMID 32884842 DOI: 10.1038/s41541-020-00227-x |
0.316 |
|
| 2020 |
Levine MM, Abdullah S, Arabi YM, Darko DM, Durbin AP, Estrada V, Jamrozik E, Kremsner PG, Lagos R, Pitisuttithum P, Plotkin SA, Sauerwein R, Shi SL, Sommerfelt H, Subbarao K, ... Treanor JJ, et al. Viewpoint of a WHO Advisory Group Tasked to Consider Establishing a Closely-Monitored Challenge Model of COVID-19 in Healthy Volunteers. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. PMID 32857836 DOI: 10.1093/cid/ciaa1290 |
0.303 |
|
| 2020 |
Treanor J. History of Live, Attenuated Influenza Vaccine. Journal of the Pediatric Infectious Diseases Society. 9: S3-S9. PMID 32191312 DOI: 10.1093/jpids/piz086 |
0.335 |
|
| 2019 |
Henry C, Palm AE, Utset HA, Huang M, Ho IY, Zheng NY, Fitzgerald T, Neu KE, Chen YQ, Krammer F, Treanor JJ, Sant AJ, Topham DJ, Wilson PC. Monoclonal antibody responses after recombinant HA vaccine versus subunit inactivated influenza virus vaccine: a comparative study. Journal of Virology. PMID 31434733 DOI: 10.1128/Jvi.01150-19 |
0.353 |
|
| 2019 |
Khurana S, Hahn M, Coyle EM, King LR, Lin TL, Treanor J, Sant A, Golding H. Repeat vaccination reduces antibody affinity maturation across different influenza vaccine platforms in humans. Nature Communications. 10: 3338. PMID 31350391 DOI: 10.1038/S41467-019-11296-5 |
0.349 |
|
| 2019 |
Li D, Wang J, Garigen J, Treanor JJ, Zand MS. Continuous Readout versus Titer-Based Assays of Influenza Vaccine Trials: Sensitivity, Specificity, and False Discovery Rates. Computational and Mathematical Methods in Medicine. 2019: 9287120. PMID 31205481 DOI: 10.1155/2019/9287120 |
0.313 |
|
| 2019 |
Henry C, Zheng NY, Huang M, Cabanov A, Rojas KT, Kaur K, Andrews SF, Palm AE, Chen YQ, Li Y, Hoskova K, Utset HA, Vieira MC, Wrammert J, Ahmed R, ... ... Treanor JJ, et al. Influenza Virus Vaccination Elicits Poorly Adapted B Cell Responses in Elderly Individuals. Cell Host & Microbe. PMID 30795982 DOI: 10.1016/J.Chom.2019.01.002 |
0.348 |
|
| 2019 |
Tesini BL, Kanagaiah P, Wang J, Hahn M, Halliley JL, Chaves FA, Nguyen PQT, Nogales A, DeDiego ML, Anderson CS, Ellebedy AH, Strohmeier S, Krammer F, Yang H, Bandyopadhyay S, ... ... Treanor JJ, et al. Broad hemagglutinin-specific memory B cell expansion by seasonal influenza virus infection reflects early-life imprinting and adaptation to the infecting virus. Journal of Virology. PMID 30728266 DOI: 10.1128/Jvi.00169-19 |
0.35 |
|
| 2019 |
Treanor J. Flu Vaccine-Too Much of a Good Thing? The Journal of Infectious Diseases. 215: 1017-1019. PMID 28180278 DOI: 10.1093/infdis/jix075 |
0.313 |
|
| 2018 |
Wang J, Hilchey SP, DeDiego M, Perry S, Hyrien O, Nogales A, Garigen J, Amanat F, Huertas N, Krammer F, Martinez-Sobrido L, Topham DJ, Treanor JJ, Sangster MY, Zand MS. Broad cross-reactive IgG responses elicited by adjuvanted vaccination with recombinant influenza hemagglutinin (rHA) in ferrets and mice. Plos One. 13: e0193680. PMID 29641537 DOI: 10.1371/Journal.Pone.0193680 |
0.342 |
|
| 2018 |
Dunkle LM, Izikson R, Patriarca PA, Goldenthal KL, Cox M, Treanor JJ. Safety and Immunogenicity of a Recombinant Influenza Vaccine: A Randomized Trial. Pediatrics. PMID 29610401 DOI: 10.1542/peds.2017-3021 |
0.334 |
|
| 2017 |
Stadlbauer D, Rajabhathor A, Amanat F, Kaplan D, Masud A, Treanor JJ, Izikson R, Cox MM, Nachbagauer R, Krammer F. Vaccination with a Recombinant H7 Hemagglutinin-Based Influenza Virus Vaccine Induces Broadly Reactive Antibodies in Humans. Msphere. 2. PMID 29242836 DOI: 10.1128/mSphere.00502-17 |
0.354 |
|
| 2017 |
Forero A, Fenstermacher K, Wohlgemuth N, Nishida A, Carter V, Smith EA, Peng X, Hayes M, Francis D, Treanor J, Morrison J, Klein SL, Lane A, Katze MG, Pekosz A. Evaluation of the innate immune responses to influenza and live-attenuated influenza vaccine infection in primary differentiated human nasal epithelial cells. Vaccine. PMID 28967519 DOI: 10.1016/J.Vaccine.2017.09.058 |
0.348 |
|
| 2017 |
Ramani S, Neill FH, Ferreira J, Treanor JJ, Frey SE, Topham DJ, Goodwin RR, Borkowski A, Baehner F, Mendelman PM, Estes MK, Atmar RL. B-Cell Responses to Intramuscular Administration of a Bivalent Virus-like Particle Human Norovirus Vaccine. Clinical and Vaccine Immunology : Cvi. PMID 28249841 DOI: 10.1128/CVI.00571-16 |
0.342 |
|
| 2017 |
Treanor JJ, Chu L, Essink B, Muse D, El Sahly HM, Izikson R, Goldenthal KL, Patriarca P, Dunkle LM. Stable emulsion (SE) alone is an effective adjuvant for a recombinant, baculovirus-expressed H5 influenza vaccine in healthy adults: A Phase 2 trial. Vaccine. PMID 28089141 DOI: 10.1016/j.vaccine.2016.12.053 |
0.317 |
|
| 2016 |
Treanor JJ. CLINICAL PRACTICE. Influenza Vaccination. The New England Journal of Medicine. 375: 1261-8. PMID 27682035 DOI: 10.1056/NEJMcp1512870 |
0.301 |
|
| 2016 |
Wright PF, Hoen AG, Ilyushina NA, Brown EP, Ackerman ME, Wieland-Alter W, Connor RI, Jegaskanda S, Rosenberg-Hasson Y, Haynes BC, Luke CJ, Subbarao K, Treanor JJ. Correlates of Immunity to Influenza as Determined by Challenge of Children with Live, Attenuated Influenza Vaccine. Open Forum Infectious Diseases. 3: ofw108. PMID 27419180 DOI: 10.1093/ofid/ofw108 |
0.318 |
|
| 2016 |
Jegaskanda S, Luke C, Hickman HD, Sangster MY, Wieland-Alter WF, McBride JM, Yewdell JW, Wright PF, Treanor J, Rosenberger CM, Subbarao K. The generation and protective ability of influenza-specific antibody-dependent cellular cytotoxicity in humans elicited by vaccination, natural infection or experimental challenge. The Journal of Infectious Diseases. PMID 27354365 DOI: 10.1093/infdis/jiw262 |
0.347 |
|
| 2016 |
Henry Dunand CJ, Leon PE, Huang M, Choi A, Chromikova V, Ho IY, Tan GS, Cruz J, Hirsh A, Zheng NY, Mullarkey CE, Ennis FA, Terajima M, Treanor JJ, Topham DJ, et al. Both Neutralizing and Non-Neutralizing Human H7N9 Influenza Vaccine-Induced Monoclonal Antibodies Confer Protection. Cell Host & Microbe. 19: 800-813. PMID 27281570 DOI: 10.1016/J.Chom.2016.05.014 |
0.312 |
|
| 2016 |
Kamath PL, Foster JT, Drees KP, Luikart G, Quance C, Anderson NJ, Clarke PR, Cole EK, Drew ML, Edwards WH, Rhyan JC, Treanor JJ, Wallen RL, White PJ, Robbe-Austerman S, et al. Genomics reveals historic and contemporary transmission dynamics of a bacterial disease among wildlife and livestock. Nature Communications. 7: 11448. PMID 27165544 DOI: 10.1038/Ncomms11448 |
0.307 |
|
| 2016 |
DeDiego ML, Anderson CS, Yang H, Holden-Wiltse J, Fitzgerald T, Treanor JJ, Topham DJ. Directed selection of influenza virus produces antigenic variants that match circulating human virus isolates and escape from vaccine mediated immune protection. Immunology. PMID 26854888 DOI: 10.1111/imm.12594 |
0.396 |
|
| 2016 |
Chung JR, Flannery B, Thompson MG, Gaglani M, Jackson ML, Monto AS, Nowalk MP, Talbot HK, Treanor JJ, Belongia EA, Murthy K, Jackson LA, Petrie JG, Zimmerman RK, Griffin MR, et al. Seasonal Effectiveness of Live Attenuated and Inactivated Influenza Vaccine. Pediatrics. PMID 26738884 DOI: 10.1542/Peds.2015-3279 |
0.322 |
|
| 2015 |
Sobhanie M, Matsuoka Y, Jegaskanda S, Fitzgerald T, Mallory R, Chen Z, Luke C, Treanor J, Subbarao K. Evaluation of the Safety and Immunogenicity of a Candidate Pandemic Live Attenuated Influenza Vaccine (pLAIV) Against Influenza A(H7N9). The Journal of Infectious Diseases. PMID 26655841 DOI: 10.1093/infdis/jiv526 |
0.308 |
|
| 2015 |
Treanor JJ. Prospects for Broadly Protective Influenza Vaccines. American Journal of Preventive Medicine. 49: S355-63. PMID 26590435 DOI: 10.1016/j.amepre.2015.09.012 |
0.343 |
|
| 2015 |
Treanor J. Editorial Commentary: Is Prepandemic Vaccination a Wise Investment? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 62: 499-500. PMID 26585521 DOI: 10.1093/cid/civ961 |
0.31 |
|
| 2015 |
Treanor JJ, Geremia C, Ballou MA, Keisler DH, White PJ, Cox JJ, Crowley PH. Maintenance of brucellosis in Yellowstone bison: linking seasonal food resources, host-pathogen interaction, and life-history trade-offs. Ecology and Evolution. 5: 3783-99. PMID 26380705 DOI: 10.1002/Ece3.1633 |
0.533 |
|
| 2015 |
Treanor JJ. Prospects for broadly protective influenza vaccines. Vaccine. PMID 26338145 DOI: 10.1016/j.vaccine.2015.08.053 |
0.343 |
|
| 2015 |
Baz M, Paskel M, Matsuoka Y, Zengel JR, Cheng X, Treanor JJ, Jin H, Subbarao K. A Single Dose of an Avian H3N8 Influenza Virus Vaccine Is Highly Immunogenic and Efficacious against a Recently Emerged Seal Influenza Virus in Mice and Ferrets. Journal of Virology. 89: 6907-17. PMID 25903333 DOI: 10.1128/JVI.00280-15 |
0.31 |
|
| 2015 |
Laguio-Vila MR, Thompson MG, Reynolds S, Spencer SM, Gaglani M, Naleway A, Ball S, Bozeman S, Baker S, Martínez-Sobrido L, Levine M, Katz J, Fry AM, Treanor JJ. Comparison of serum hemagglutinin and neuraminidase inhibition antibodies after 2010-2011 trivalent inactivated influenza vaccination in healthcare personnel. Open Forum Infectious Diseases. 2: ofu115. PMID 25884004 DOI: 10.1093/ofid/ofu115 |
0.355 |
|
| 2015 |
Halliley JL, Khurana S, Krammer F, Fitzgerald T, Coyle EM, Chung KY, Baker SF, Yang H, Martínez-Sobrido L, Treanor JJ, Subbarao K, Golding H, Topham DJ, Sangster MY. High-Affinity H7 Head and Stalk Domain-Specific Antibody Responses to an Inactivated Influenza H7N7 Vaccine After Priming With Live Attenuated Influenza Vaccine. The Journal of Infectious Diseases. PMID 25838266 DOI: 10.1093/infdis/jiv210 |
0.301 |
|
| 2015 |
Sundararajan A, Sangster MY, Frey S, Atmar RL, Chen WH, Ferreira J, Bargatze R, Mendelman PM, Treanor JJ, Topham DJ. Robust mucosal-homing antibody-secreting B cell responses induced by intramuscular administration of adjuvanted bivalent human norovirus-like particle vaccine. Vaccine. 33: 568-76. PMID 25444793 DOI: 10.1016/j.vaccine.2014.09.073 |
0.345 |
|
| 2015 |
Baz M, Paskel M, Matsuoka Y, Zengel J, Cheng X, Treanor JJ, Jin H, Subbarao K. A live attenuated equine H3N8 influenza vaccine is highly immunogenic and efficacious in mice and ferrets. Journal of Virology. 89: 1652-9. PMID 25410860 DOI: 10.1128/JVI.02449-14 |
0.341 |
|
| 2015 |
Bernstein DI, Atmar RL, Lyon GM, Treanor JJ, Chen WH, Jiang X, Vinjé J, Gregoricus N, Frenck RW, Moe CL, Al-Ibrahim MS, Barrett J, Ferreira J, Estes MK, Graham DY, et al. Norovirus vaccine against experimental human GII.4 virus illness: a challenge study in healthy adults. The Journal of Infectious Diseases. 211: 870-8. PMID 25210140 DOI: 10.1093/Infdis/Jiu497 |
0.334 |
|
| 2015 |
Ilyushina NA, Haynes BC, Hoen AG, Khalenkov AM, Housman ML, Brown EP, Ackerman ME, Treanor JJ, Luke CJ, Subbarao K, Wright PF. Live attenuated and inactivated influenza vaccines in children. The Journal of Infectious Diseases. 211: 352-60. PMID 25165161 DOI: 10.1093/infdis/jiu458 |
0.322 |
|
| 2015 |
Hobbs NT, Geremia C, Treanor J, Wallen R, White PJ, Hooten MB, Rhyan JC. State‐space modeling to support management of brucellosis in the Yellowstone bison population Ecological Monographs. 85: 525-556. DOI: 10.1890/14-1413.1 |
0.326 |
|
| 2014 |
Babu TM, Levine M, Fitzgerald T, Luke C, Sangster MY, Jin H, Topham D, Katz J, Treanor J, Subbarao K. Live attenuated H7N7 influenza vaccine primes for a vigorous antibody response to inactivated H7N7 influenza vaccine. Vaccine. 32: 6798-804. PMID 25446831 DOI: 10.1016/J.Vaccine.2014.09.070 |
0.317 |
|
| 2014 |
Donahue JG, Kieke BA, Szilagy PG, Blumkin AK, Hilgemann D, Flanders WD, Shay DK, Meece J, Gallivan S, Treanor J, Belongia EA. Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines? Vaccine. 32: 6440-4. PMID 25284810 DOI: 10.1016/J.Vaccine.2014.09.051 |
0.331 |
|
| 2014 |
O'Donnell CD, Wright A, Vogel L, Boonnak K, Treanor JJ, Subbarao K. Humans and ferrets with prior H1N1 influenza virus infections do not exhibit evidence of original antigenic sin after infection or vaccination with the 2009 pandemic H1N1 influenza virus. Clinical and Vaccine Immunology : Cvi. 21: 737-46. PMID 24648486 DOI: 10.1128/CVI.00790-13 |
0.339 |
|
| 2014 |
Krammer F, Albrecht RA, Tan GS, Margine I, Hai R, Schmolke M, Runstadler J, Andrews SF, Wilson PC, Cox RJ, Treanor JJ, GarcÃa-Sastre A, Palese P. Divergent H7 immunogens offer protection from H7N9 virus challenge. Journal of Virology. 88: 3976-85. PMID 24453375 DOI: 10.1128/Jvi.03095-13 |
0.371 |
|
| 2014 |
Durviaux S, Treanor J, Beran J, Duval X, Esen M, Feldman G, Frey SE, Launay O, Leroux-Roels G, McElhaney JE, Nowakowski A, Ruiz-Palacios GM, van Essen GA, Oostvogels L, Devaster JM, et al. Genetic and antigenic typing of seasonal influenza virus breakthrough cases from a 2008-2009 vaccine efficacy trial. Clinical and Vaccine Immunology : Cvi. 21: 271-9. PMID 24371255 DOI: 10.1128/CVI.00544-13 |
0.305 |
|
| 2014 |
Goodwin R, Bernstein D, Atmar RL, Lyon GM, Treanor JJ, Chen WH, Frenck RW, Jiang X, Vinje J, Al-Ibrahim MS, Barrett J, Graham DY, Borkowski A, Clemens R, Mendelman PM. Reduction in vomiting associated with norovirus vaccination in a live norovirus human challenge study International Journal of Infectious Diseases. 21: 434-435. DOI: 10.1016/J.Ijid.2014.03.1316 |
0.31 |
|
| 2013 |
Jackson LA, Gurtman A, van Cleeff M, Frenck RW, Treanor J, Jansen KU, Scott DA, Emini EA, Gruber WC, Schmoele-Thoma B. Influence of initial vaccination with 13-valent pneumococcal conjugate vaccine or 23-valent pneumococcal polysaccharide vaccine on anti-pneumococcal responses following subsequent pneumococcal vaccination in adults 50 years and older. Vaccine. 31: 3594-602. PMID 23688525 DOI: 10.1016/j.vaccine.2013.04.084 |
0.329 |
|
| 2013 |
Poland GA, Fleming DM, Treanor JJ, Maraskovsky E, Luke TC, Ball EM, Poland CM. New Wisdom to Defy an Old Enemy: Summary from a scientific symposium at the 4th Influenza Vaccines for the World (IVW) 2012 Congress, 11 October, Valencia, Spain. Vaccine. 31: A1-20. PMID 23587330 DOI: 10.1016/j.vaccine.2013.02.033 |
0.356 |
|
| 2013 |
Sangster MY, Baer J, Santiago FW, Fitzgerald T, Ilyushina NA, Sundararajan A, Henn AD, Krammer F, Yang H, Luke CJ, Zand MS, Wright PF, Treanor JJ, Topham DJ, Subbarao K. B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination. Clinical and Vaccine Immunology : Cvi. 20: 867-76. PMID 23576673 DOI: 10.1128/Cvi.00735-12 |
0.325 |
|
| 2013 |
Treanor JJ, Szilagyi P. Editorial commentary: influenza vaccine: glass half full or half empty? Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 56: 1370-2. PMID 23413421 DOI: 10.1093/cid/cit064 |
0.319 |
|
| 2013 |
Margine I, Hai R, Albrecht RA, Obermoser G, Harrod AC, Banchereau J, Palucka K, GarcÃa-Sastre A, Palese P, Treanor JJ, Krammer F. H3N2 influenza virus infection induces broadly reactive hemagglutinin stalk antibodies in humans and mice. Journal of Virology. 87: 4728-37. PMID 23408625 DOI: 10.1128/Jvi.03509-12 |
0.317 |
|
| 2013 |
Gurwith M, Lock M, Taylor EM, Ishioka G, Alexander J, Mayall T, Ervin JE, Greenberg RN, Strout C, Treanor JJ, Webby R, Wright PF. Safety and immunogenicity of an oral, replicating adenovirus serotype 4 vector vaccine for H5N1 influenza: a randomised, double-blind, placebo-controlled, phase 1 study. The Lancet. Infectious Diseases. 13: 238-50. PMID 23369412 DOI: 10.1016/S1473-3099(12)70345-6 |
0.309 |
|
| 2013 |
He XS, Sasaki S, Baer J, Khurana S, Golding H, Treanor JJ, Topham DJ, Sangster MY, Jin H, Dekker CL, Subbarao K, Greenberg HB. Heterovariant cross-reactive B-cell responses induced by the 2009 pandemic influenza virus A subtype H1N1 vaccine. The Journal of Infectious Diseases. 207: 288-96. PMID 23107783 DOI: 10.1093/Infdis/Jis664 |
0.356 |
|
| 2012 |
Ilyushina NA, Ikizler MR, Kawaoka Y, Rudenko LG, Treanor JJ, Subbarao K, Wright PF. Comparative study of influenza virus replication in MDCK cells and in primary cells derived from adenoids and airway epithelium. Journal of Virology. 86: 11725-34. PMID 22915797 DOI: 10.1128/Jvi.01477-12 |
0.333 |
|
| 2012 |
Treanor JJ, Talbot HK, Ohmit SE, Coleman LA, Thompson MG, Cheng PY, Petrie JG, Lofthus G, Meece JK, Williams JV, Berman L, Breese Hall C, Monto AS, Griffin MR, Belongia E, et al. Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains. Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 55: 951-9. PMID 22843783 DOI: 10.1093/Cid/Cis574 |
0.346 |
|
| 2011 |
Griffin MR, Monto AS, Belongia EA, Treanor JJ, Chen Q, Chen J, Talbot HK, Ohmit SE, Coleman LA, Lofthus G, Petrie JG, Meece JK, Hall CB, Williams JV, Gargiullo P, et al. Effectiveness of non-adjuvanted pandemic influenza A vaccines for preventing pandemic influenza acute respiratory illness visits in 4 U.S. communities. Plos One. 6: e23085. PMID 21857999 DOI: 10.1371/Journal.Pone.0023085 |
0.345 |
|
| 2011 |
Treanor JJ, El Sahly H, King J, Graham I, Izikson R, Kohberger R, Patriarca P, Cox M. Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: a randomized, placebo-controlled trial. Vaccine. 29: 7733-9. PMID 21835220 DOI: 10.1016/j.vaccine.2011.07.128 |
0.341 |
|
| 2011 |
Frenck RW, Belshe R, Brady RC, Winokur PL, Campbell JD, Treanor J, Hay CM, Dekker CL, Walter EB, Cate TR, Edwards KM, Hill H, Wolff M, Leduc T, Tornieporth N. Comparison of the immunogenicity and safety of a split-virion, inactivated, trivalent influenza vaccine (Fluzone®) administered by intradermal and intramuscular route in healthy adults. Vaccine. 29: 5666-74. PMID 21699951 DOI: 10.1016/j.vaccine.2011.06.010 |
0.319 |
|
| 2011 |
Taylor DN, Treanor JJ, Strout C, Johnson C, Fitzgerald T, Kavita U, Ozer K, Tussey L, Shaw A. Induction of a potent immune response in the elderly using the TLR-5 agonist, flagellin, with a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125, STF2.HA1 SI). Vaccine. 29: 4897-902. PMID 21596084 DOI: 10.1016/J.Vaccine.2011.05.001 |
0.342 |
|
| 2011 |
Geremia C, White PJ, Wallen RL, Watson FG, Treanor JJ, Borkowski J, Potter CS, Crabtree RL. Predicting bison migration out of Yellowstone National Park using bayesian models. Plos One. 6: e16848. PMID 21340035 DOI: 10.1371/Journal.Pone.0016848 |
0.306 |
|
| 2011 |
Ebinger M, Cross P, Wallen R, White PJ, Treanor J. Simulating sterilization, vaccination, and test-and-remove as brucellosis control measures in bison Ecological Applications. 21: 2944-2959. DOI: 10.1890/10-2239.1 |
0.455 |
|
| 2011 |
Treanor JJ, Geremia C, Crowley PH, Cox JJ, White PJ, Wallen RL, Blanton DW. Estimating probabilities of active brucellosis infection in Yellowstone bison through quantitative serology and tissue culture Journal of Applied Ecology. 48: 1324-1332. DOI: 10.1111/J.1365-2664.2011.02058.X |
0.554 |
|
| 2011 |
White PJ, Wallen RL, Geremia C, Treanor JJ, Blanton DW. Management of Yellowstone bison and brucellosis transmission risk - Implications for conservation and restoration Biological Conservation. 144: 1322-1334. DOI: 10.1016/J.Biocon.2011.01.003 |
0.34 |
|
| 2010 |
Treanor JJ, Taylor DN, Tussey L, Hay C, Nolan C, Fitzgerald T, Liu G, Kavita U, Song L, Dark I, Shaw A. Safety and immunogenicity of a recombinant hemagglutinin influenza-flagellin fusion vaccine (VAX125) in healthy young adults. Vaccine. 28: 8268-74. PMID 20969925 DOI: 10.1016/j.vaccine.2010.10.009 |
0.325 |
|
| 2010 |
Treanor JJ, Johnson JS, Wallen RL, Cilles S, Crowley PH, Cox JJ, Maehr DS, White PJ, Plumb GE. Vaccination strategies for managing brucellosis in Yellowstone bison. Vaccine. 28: F64-72. PMID 20362620 DOI: 10.1016/J.Vaccine.2010.03.055 |
0.58 |
|
| 2010 |
Jackson LA, Gaglani MJ, Keyserling HL, Balser J, Bouveret N, Fries L, Treanor JJ. Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons. Bmc Infectious Diseases. 10: 71. PMID 20236548 DOI: 10.1186/1471-2334-10-71 |
0.332 |
|
| 2010 |
Bernard MP, Bancos S, Chapman TJ, Ryan EP, Treanor JJ, Rose RC, Topham DJ, Phipps RP. Chronic inhibition of cyclooxygenase-2 attenuates antibody responses against vaccinia infection. Vaccine. 28: 1363-72. PMID 19941994 DOI: 10.1016/J.Vaccine.2009.11.005 |
0.3 |
|
| 2010 |
Jones JD, Treanor JJ, Wallen RL, White PJ. Timing of parturition events in Yellowstone bison Bison bison: Implications for bison conservation and brucellosis transmission risk to cattle Wildlife Biology. 16: 333-339. DOI: 10.2981/09-082 |
0.358 |
|
| 2009 |
Keitel WA, Treanor JJ, El Sahly HM, Gilbert A, Meyer AL, Patriarca PA, Cox MM. Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccine (TIV) among persons > or =65 years old. Vaccine. 28: 379-85. PMID 19879222 DOI: 10.1016/j.vaccine.2009.10.037 |
0.348 |
|
| 2009 |
Treanor J. Recombinant proteins produced in insect cells Current Topics in Microbiology and Immunology. 333: 211-225. PMID 19768408 DOI: 10.1007/978-3-540-92165-3_11 |
0.351 |
|
| 2009 |
Brady RC, Treanor JJ, Atmar RL, Keitel WA, Edelman R, Chen WH, Winokur P, Belshe R, Graham IL, Noah DL, Guo K, Hill H. Safety and immunogenicity of a subvirion inactivated influenza A/H5N1 vaccine with or without aluminum hydroxide among healthy elderly adults. Vaccine. 27: 5091-5. PMID 19577636 DOI: 10.1016/j.vaccine.2009.06.057 |
0.34 |
|
| 2009 |
Falsey AR, Treanor JJ, Tornieporth N, Capellan J, Gorse GJ. Randomized, double-blind controlled phase 3 trial comparing the immunogenicity of high-dose and standard-dose influenza vaccine in adults 65 years of age and older. The Journal of Infectious Diseases. 200: 172-80. PMID 19508159 DOI: 10.1086/599790 |
0.32 |
|
| 2009 |
Cox MM, Patriarca PA, Treanor J. FluBlok, a recombinant hemagglutinin influenza vaccine. Influenza and Other Respiratory Viruses. 2: 211-9. PMID 19453397 DOI: 10.1111/j.1750-2659.2008.00053.x |
0.331 |
|
| 2009 |
Cox MM, Patriarca PA, Treanor J. FluBlok, a recombinant hemagglutinin influenza vaccine. Influenza and Other Respiratory Viruses. 2: 211-9. PMID 19453397 DOI: 10.1111/j.1750-2659.2008.00053.x |
0.331 |
|
| 2009 |
Crompton PD, Mircetic M, Weiss G, Baughman A, Huang CY, Topham DJ, Treanor JJ, Sanz I, Lee FE, Durbin AP, Miura K, Narum DL, Ellis RD, Malkin E, Mullen GE, et al. The TLR9 ligand CpG promotes the acquisition of Plasmodium falciparum-specific memory B cells in malaria-naive individuals. Journal of Immunology (Baltimore, Md. : 1950). 182: 3318-26. PMID 19234231 DOI: 10.4049/Jimmunol.0803596 |
0.312 |
|
| 2008 |
Engler RJ, Nelson MR, Klote MM, VanRaden MJ, Huang CY, Cox NJ, Klimov A, Keitel WA, Nichol KL, Carr WW, Treanor JJ. Half- vs full-dose trivalent inactivated influenza vaccine (2004-2005): age, dose, and sex effects on immune responses. Archives of Internal Medicine. 168: 2405-14. PMID 19064822 DOI: 10.1001/archinternmed.2008.513 |
0.325 |
|
| 2008 |
Goji NA, Nolan C, Hill H, Wolff M, Noah DL, Williams TB, Rowe T, Treanor JJ. Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant. The Journal of Infectious Diseases. 198: 635-41. PMID 18694338 DOI: 10.1086/590916 |
0.301 |
|
| 2008 |
Talbot HK, Keitel W, Cate TR, Treanor J, Campbell J, Brady RC, Graham I, Dekker CL, Ho D, Winokur P, Walter E, Bennet J, Formica N, Hartel G, Skeljo M, et al. Immunogenicity, safety and consistency of new trivalent inactivated influenza vaccine. Vaccine. 26: 4057-61. PMID 18602726 DOI: 10.1016/j.vaccine.2008.05.024 |
0.335 |
|
| 2007 |
Rajagopal S, Treanor J. Pandemic (avian) influenza Seminars in Respiratory and Critical Care Medicine. 28: 159-170. PMID 17458770 DOI: 10.1055/s-2007-976488 |
0.303 |
|
| 2007 |
Treanor JJ, Schiff GM, Hayden FG, Brady RC, Hay CM, Meyer AL, Holden-Wiltse J, Liang H, Gilbert A, Cox M. Safety and immunogenicity of a baculovirus-expressed hemagglutinin influenza vaccine: a randomized controlled trial. Jama. 297: 1577-82. PMID 17426277 DOI: 10.1001/Jama.297.14.1577 |
0.329 |
|
| 2006 |
Nichol KL, Treanor JJ. Vaccines for seasonal and pandemic influenza. The Journal of Infectious Diseases. 194: S111-8. PMID 17163383 DOI: 10.1086/507544 |
0.363 |
|
| 2006 |
Treanor J, Wu H, Liang H, Topham DJ. Immune responses to vaccinia and influenza elicited during primary versus recent or distant secondary smallpox vaccination of adults Vaccine. 24: 6913-6923. PMID 17014939 DOI: 10.1016/J.Vaccine.2006.06.006 |
0.307 |
|
| 2006 |
Ward JI, Cherry JD, Chang SJ, Partridge S, Keitel W, Edwards K, Lee M, Treanor J, Greenberg DP, Barenkamp S, Bernstein DI, Edelman R. Bordetella Pertussis infections in vaccinated and unvaccinated adolescents and adults, as assessed in a national prospective randomized Acellular Pertussis Vaccine Trial (APERT). Clinical Infectious Diseases : An Official Publication of the Infectious Diseases Society of America. 43: 151-7. PMID 16779740 DOI: 10.1086/504803 |
0.324 |
|
| 2006 |
Treanor JJ, Schiff GM, Couch RB, Cate TR, Brady RC, Hay CM, Wolff M, She D, Cox MM. Dose-related safety and immunogenicity of a trivalent baculovirus-expressed influenza-virus hemagglutinin vaccine in elderly adults. The Journal of Infectious Diseases. 193: 1223-8. PMID 16586358 DOI: 10.1086/503050 |
0.302 |
|
| 2006 |
Treanor JJ, Campbell JD, Zangwill KM, Rowe T, Wolff M. Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine. The New England Journal of Medicine. 354: 1343-51. PMID 16571878 DOI: 10.1056/NEJMoa055778 |
0.313 |
|
| 2006 |
Wright PF, Karron RA, Madhi SA, Treanor JJ, King JC, O'Shea A, Ikizler MR, Zhu Y, Collins PL, Cutland C, Randolph VB, Deatly AM, Hackell JG, Gruber WC, Murphy BR. The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans. The Journal of Infectious Diseases. 193: 573-81. PMID 16425137 DOI: 10.1086/499600 |
0.326 |
|
| 2006 |
Treanor J, Nolan C, O'Brien D, Burt D, Lowell G, Linden J, Fries L. Intranasal administration of a proteosome-influenza vaccine is well-tolerated and induces serum and nasal secretion influenza antibodies in healthy human subjects Vaccine. 24: 254-262. PMID 16129526 DOI: 10.1016/j.vaccine.2005.07.088 |
0.329 |
|
| 2006 |
Treanor J. The Cutter Incident: How America’s First Polio Vaccine Led to the Growing Vaccine Crisis Environmental Health Perspectives. 114. DOI: 10.1289/ehp.114-a556a |
0.319 |
|
| 2005 |
Halperin SA, Smith B, Clarke K, Treanor J, Mabrouk T, Germain M. Phase I, randomized, controlled trial to study the reactogenicity and immunogenicity of a nasal, inactivated trivalent influenza virus vaccine in healthy adults Human Vaccines. 1: 37-42. PMID 17038827 |
0.31 |
|
| 2005 |
Treanor JJ, Campbell JD, Brady RC, Keitel WA, Drame M, Jain VK, Innis BL. Rapid licensure of a new, inactivated influenza vaccine in the United States. Human Vaccines. 1: 239-44. PMID 17012883 |
0.332 |
|
| 2005 |
Ward JI, Cherry JD, Chang SJ, Partridge S, Lee H, Treanor J, Greenberg DP, Keitel W, Barenkamp S, Bernstein DI, Edelman R, Edwards K. Efficacy of an acellular pertussis vaccine among adolescents and adults. The New England Journal of Medicine. 353: 1555-63. PMID 16221778 DOI: 10.1056/NEJMoa050824 |
0.309 |
|
| 2004 |
Moynihan JA, Larson MR, Treanor J, Duberstein PR, Power A, Shore B, Ader R. Psychosocial factors and the response to influenza vaccination in older adults. Psychosomatic Medicine. 66: 950-3. PMID 15564363 DOI: 10.1097/01.Psy.0000140001.49208.2D |
0.306 |
|
| 2004 |
Belshe RB, Newman FK, Cannon J, Duane C, Treanor J, Van Hoecke C, Howe BJ, Dubin G. Serum antibody responses after intradermal vaccination against influenza New England Journal of Medicine. 351: 2286-2294. PMID 15525713 DOI: 10.1056/NEJMoa043555 |
0.326 |
|
| 2004 |
Treanor J. Weathering the influenza vaccine crisis New England Journal of Medicine. 351: 2037-2040. PMID 15492296 DOI: 10.1056/NEJMp048290 |
0.331 |
|
| 2004 |
Geier MR, Geier DA, Pichichero ME, Treanor J. Mercury in vaccines and potential conflicts of interest [4] (multiple letters) Lancet. 364: 1217-1218. PMID 15464179 DOI: 10.1016/S0140-6736(04)17134-1 |
0.306 |
|
| 2004 |
Lee FE, Walsh EE, Falsey AR, Betts RF, Treanor JJ. Experimental infection of humans with A2 respiratory syncytial virus. Antiviral Research. 63: 191-6. PMID 15451187 DOI: 10.1016/j.antiviral.2004.04.005 |
0.302 |
|
| 2004 |
Belshe RB, Newman FK, Frey SE, Couch RB, Treanor JJ, Tacket CO, Yan L. Dose-dependent neutralizing-antibody responses to vaccinia. The Journal of Infectious Diseases. 189: 493-7. PMID 14745707 DOI: 10.1086/380906 |
0.323 |
|
| 2004 |
Treanor J. Influenza Vaccine - Outmaneuvering Antigenic Shift and Drift New England Journal of Medicine. 350: 218-220. PMID 14724300 DOI: 10.1056/NEJMp038238 |
0.33 |
|
| 2003 |
Bernstein DI, Yan L, Treanor J, Mendelman PM, Belshe R. Effect of yearly vaccinations with live, attenuated, cold-adapted, trivalent, intranasal influenza vaccines on antibody responses in children. The Pediatric Infectious Disease Journal. 22: 28-34. PMID 12544405 DOI: 10.1097/00006454-200301000-00010 |
0.331 |
|
| 2002 |
Frey SE, Couch RB, Tacket CO, Treanor JJ, Wolff M, Newman FK, Atmar RL, Edelman R, Nolan CM, Belshe RB. Clinical responses to undiluted and diluted smallpox vaccine. The New England Journal of Medicine. 346: 1265-74. PMID 11923490 DOI: 10.1056/NEJMoa020534 |
0.334 |
|
| 2002 |
Halperin SA, Smith B, Mabrouk T, Germain M, Trépanier P, Hassell T, Treanor J, Gauthier R, Mills EL. Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children. Vaccine. 20: 1240-7. PMID 11803087 DOI: 10.1016/S0264-410X(01)00428-5 |
0.316 |
|
| 2002 |
Treanor J, Keitel W, Belshe R, Campbell J, Schiff G, Zangwill K, Wolff M, Klimov A, Levandowski R, Lambert L. Evaluation of a single dose of half strength inactivated influenza vaccine in healthy adults Vaccine. 20: 1099-1105. PMID 11803070 DOI: 10.1016/S0264-410X(01)00440-6 |
0.334 |
|
| 2000 |
Belshe RB, Gruber WC, Mendelman PM, Mehta HB, Mahmood K, Reisinger K, Treanor J, Zangwill K, Hayden FG, Bernstein DI, Kotloff K, King J, Piedra PA, Block SL, Yan L, et al. Correlates of immune protection induced by live, attenuated, cold- adapted, trivalent, intranasal influenza virus vaccine Journal of Infectious Diseases. 181: 1133-1137. PMID 10720541 DOI: 10.1086/315323 |
0.372 |
|
| 2000 |
Betts RF, Treanor JJ. Approaches to improved influenza vaccination. Vaccine. 18: 1690-5. PMID 10689150 DOI: 10.1016/S0264-410X(99)00508-3 |
0.384 |
|
| 2000 |
Treanor J, Falsey A. Respiratory viral infections in the elderly. Antiviral Research. 44: 79-102. PMID 10669259 DOI: 10.1016/S0166-3542(99)00062-5 |
0.37 |
|
| 2000 |
Belshe RB, Gruber WC, Mendelman PM, Cho I, Reisinger K, Block SL, Wittes J, Iacuzio D, Piedra P, Treanor J, King J, Kotloff K, Bernstein DI, Hayden FG, Zangwill K, et al. Efficacy of vaccination with live attenuated, cold-adapted, trivalent, intranasal influenza virus vaccine against a variant (A/Sydney) not contained in the vaccine Journal of Pediatrics. 136: 168-175. PMID 10657821 DOI: 10.1016/S0022-3476(00)70097-7 |
0.343 |
|
| 1999 |
Treanor JJ, Kotloff K, Betts RF, Belshe R, Newman F, Iacuzio D, Wittes J, Bryant M. Evaluation of trivalent, live, cold-adapted (CAIV-T) and inactivated (TIV) influenza vaccines in prevention of virus infection and illness following challenge of adults with wild-type influenza A (H1N1), A (H3N2), and B viruses. Vaccine. 18: 899-906. PMID 10580204 DOI: 10.1016/S0264-410X(99)00334-5 |
0.314 |
|
| 1999 |
Hasan MS, Agosti JM, Reynolds KK, Tanzman E, Treanor JJ, Evans TG. Granulocyte macrophage colony-stimulating factor as an adjuvant for hepatitis B vaccination of healthy adults. The Journal of Infectious Diseases. 180: 2023-6. PMID 10558962 DOI: 10.1086/315129 |
0.306 |
|
| 1998 |
Treanor JJ, Betts RF. Evaluation of live, cold-adapted influenza A and B virus vaccines in elderly and high-risk subjects. Vaccine. 16: 1756-60. PMID 9778752 DOI: 10.1016/S0264-410X(98)00136-4 |
0.357 |
|
| 1998 |
Tasker SA, O'Brien WA, Treanor JJ, Weiss PJ, Olson PE, Kaplan AH, Wallace MR. Effects of influenza vaccination in HIV-infected adults: a double-blind, placebo-controlled trial. Vaccine. 16: 1039-42. PMID 9682356 DOI: 10.1016/S0264-410X(97)00275-2 |
0.317 |
|
| 1998 |
Belshe RB, Mendelman PM, Treanor J, King J, Gruber WC, Piedra P, Bernstein DI, Hayden FG, Kotloff K, Zangwill K, Iacuzio D, Wolff M, Reisinger K, Block SL, Wittes J, et al. The efficacy of live attenuated, cold-adapted, trivalent, intranasal influenzavirus vaccine in children New England Journal of Medicine. 338: 1405-1412. PMID 9580647 DOI: 10.1056/Nejm199805143382002 |
0.329 |
|
| 1997 |
Shelly MA, Jacoby H, Riley GJ, Graves BT, Pichichero M, Treanor JJ. Comparison of pneumococcal polysaccharide and CRM197-conjugated pneumococcal oligosaccharide vaccines in young and elderly adults. Infection and Immunity. 65: 242-7. PMID 8975918 DOI: 10.1128/iai.65.1.242-247.1997 |
0.303 |
|
| 1996 |
Lakey DL, Treanor JJ, Betts RF, Smith GE, Thompson J, Sannella E, Reed G, Wilkinson BE, Wright PF. Recombinant baculovirus influenza A hemagglutinin vaccines are well tolerated and immunogenic in healthy adults. The Journal of Infectious Diseases. 174: 838-41. PMID 8843225 DOI: 10.1093/INFDIS/174.4.838 |
0.328 |
|
| 1996 |
Treanor JJ, Betts RF, Smith GE, Anderson EL, Hackett CS, Wilkinson BE, Belshe RB, Powers DC. Evaluation of a recombinant hemagglutinin expressed in insect cells as an influenza vaccine in young and elderly adults. The Journal of Infectious Diseases. 173: 1467-70. PMID 8648221 DOI: 10.1093/INFDIS/173.6.1467 |
0.335 |
|
| 1995 |
Powers DC, Smith GE, Anderson EL, Kennedy DJ, Hackett CS, Wilkinson BE, Volvovitz F, Belshe RB, Treanor JJ. Influenza A virus vaccines containing purified recombinant H3 hemagglutinin are well tolerated and induce protective immune responses in healthy adults. The Journal of Infectious Diseases. 171: 1595-9. PMID 7769297 DOI: 10.1093/INFDIS/171.6.1595 |
0.372 |
|
| 1995 |
Treanor JJ, Clark HF, Pichichero M, Christy C, Gouvea V, Shrager D, Palazzo S, Offit P. Evaluation of the protective efficacy of a serotype 1 bovine-human rotavirus reassortant vaccine in infants. The Pediatric Infectious Disease Journal. 14: 301-7. PMID 7603812 DOI: 10.1097/00006454-199504000-00010 |
0.325 |
|
| 1994 |
Treanor J, Dumyati G, O'Brien D, Riley MA, Riley G, Erb S, Betts R. Evaluation of cold-adapted, reassortant influenza B virus vaccines in elderly and chronically ill adults. The Journal of Infectious Diseases. 169: 402-7. PMID 8106775 DOI: 10.1093/infdis/169.2.402 |
0.351 |
|
| 1993 |
Treanor JJ, Betts RF. Evaluation of live attenuated cold-adapted influenza B/Yamagata/16/88 reassortant virus vaccine in healthy adults. The Journal of Infectious Diseases. 168: 455-9. PMID 8335984 DOI: 10.1093/INFDIS/168.2.455 |
0.326 |
|
| 1992 |
Treanor JJ, Mattison HR, Dumyati G, Yinnon A, Erb S, O'Brien D, Dolin R, Betts RF. Protective efficacy of combined live intranasal and inactivated influenza A virus vaccines in the elderly. Annals of Internal Medicine. 117: 625-33. PMID 1530193 DOI: 10.7326/0003-4819-117-8-625 |
0.326 |
|
| 1990 |
Treanor JJ, Roth FK, Betts RF. Use of live cold-adapted influenza A H1N1 and H3N2 virus vaccines in seropositive adults. Journal of Clinical Microbiology. 28: 596-9. PMID 2182673 DOI: 10.1128/jcm.28.3.596-599.1990 |
0.327 |
|
| 1985 |
Christy C, Treanor JJ, Madore HP, Chanock RM, Kapikian AZ, Dolin R, Hall CB. 1074 SAFETY AND IMMUNOGENICITY OF A LIVE ATTENUATED RHESUS MONKEY ROTAVIRUS VACCINE Pediatric Research. 19: 289A-289A. DOI: 10.1203/00006450-198504000-01104 |
0.302 |
|
| Show low-probability matches. |